| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |